|
| |
Image Results
Loading...
Loading...
Astrocytoma Drug Discovery 2009 Pages on BioPortfolio:
|
BioPortfolio - IL13RA2 - interleukin 13 receptor, alpha 2
Monday November 16 2009 | Biotechnology feed | All feeds · BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery
Disease ... targets representing molecular denominators of high-grade
astrocytomas. ...
http://www.bioportfolio.com/gene/3598-IL13RA2.html...
|
BioPortfolio - PTEN - phosphatase and tensin homolog (mutated in ...
High-grade astrocytomas (AAs and GBMs) had elevated fractions of tumor cells with ... Inc., a privately held cancer drug discovery and development company,
today announced that ... Innovations Report: Oct 14 2009 11:12AM Matching: pten
...
http://www.bioportfolio.com/gene/5728-PTEN.html...
|
BioPortfolio - ADORA3 - adenosine A3 receptor
... Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease ... 12435805, A(3) receptors, in astrocytoma cells, are regulated after short- and
... 10th September, 2009, Department of Genetic Medicine, Weill Cornel Medical
...
http://www.bioportfolio.com/gene/140-ADORA3.html...
|
BioPortfolio - CUGBP2 - CUG triplet repeat, RNA binding protein 2
... Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease ... 29th October, 2009, Department of Biological Sciences, University of
... Pilocytic astrocytomas (PAs) are World Health Organization Grade I.. ...
http://www.bioportfolio.com/gene/10659-CUGBP2.html...
|
BioPortfolio - Fever Of Unknown Origin
[A case of pontine astrocytoma with unusual neuroimaging features] ... Delivers Blow to Darwin, 17th November, 2009, Discovery Institute, CRACKS AMAZON. ...
http://www.bioportfolio.com/indepth/Fever_Of_Unknown_Origin....
|
BioPortfolio - EPHA2 - EPH receptor A2
Business Wire via Yahoo!: Aug 26 2009 11:33AM Matching: epha2. Seattle Genetics Achieves Milestone Under Antibody-Drug Conjugate Collaboration with ...
http://www.bioportfolio.com/gene/1969-EPHA2.html...
|
BioPortfolio - AGY Therapeutics - Profile
Astrocytomas are the most frequent brain tumour type in adults. ... AGY Therapeutics Inc., Drug Discovery, 270 East Grand Avenue, South San- J
Neurooncol. 2005 ... Halozyme Therapeutics, Inc. Q3 2009 Earnings Call
Transcript ...
http://www.bioportfolio.com/biocorporate/18072-AGY+Therapeut...
| Results from other life science and pharmaceutical sites:
Laboratory Investigation - Abstract of article: Albumin marks ...
11 Sep 2006 ... Albumin marks pseudopodia of astrocytoma cells responding to hepatocyte growth factor or ... Central Drug Research Institute; Lucknow, India ...
http://www.nature.com/labinvest/journal/v86/n11/abs/3700470a...
|
Meta-analysis of glioblastoma multiforme versus anaplastic ...
Received February 23, 2009; Accepted September 4, 2009. ... Anaplastic astrocytoma (AA) and its more aggressive counterpart, glioblastoma multiforme
...... enhances apoptosis of chemotherapeutic drug-resistant cancer stem cells.
.... Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical
and ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743637/...
|
Eye - Abstract of article: Epipapillary isolated astrocytoma ...
Epipapillary isolated astrocytoma associated with branch retinal artery ... Chemistry · Drug discovery · Biotechnology · Materials · Methods & Protocols ...
http://www.nature.com/eye/journal/v20/n12/abs/6702365a.html...
|
Pharmaceutical research and development in India
tier of drug discovery in India and the challenges and opportunities facing pharmaceutical .... CELL NOTES ISSUE 23 2009. PHARMACEUTICAL R&D IN INDIA. DRUG
SCREENING ... grade III aggressive mouse anaplastic astrocytoma). The green ...
http://www.promega.com/cnotes/cn023/cn023_03.pdf...
|
Temozolomide: Drug Information Provided by Lexi-Comp: Merck Manual ...
Anaplastic astrocytoma (refractory): Initial dose: 150 mg/m2/day for 5 days; .... Wedge SR, et al, “Temozolomide: A Review of Its Discovery, Chemical
Properties, ... of the EORTC-NCIC Trial,” Lancet Oncol, 2009 [epub ahead of
print] ...
http://www.merck.com/mmpe/lexicomp/temozolomide.html...
|
Stat3 Expression and Its Correlation with Proliferation and ...
Published online 2009 April 27. doi: 10.1155/2008/219241. ..... In grade II astrocytomas and oligodendrogliomas, the staining was mostly nuclear and was
scored as “A”. ..... Nature Reviews Drug Discovery. 2007;6(4):304–312. [PubMed]
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674606/...
|
Cell Notes Issue 23: Drug Screening
India to serve as the Senior Vice President of Drug Discovery .... CELL NOTES ISSUE 23 2009. PHARMACEUTICAL R&D IN INDIA. DRUG SCREENING molecule—one molecule
that can ... grade III aggressive mouse anaplastic astrocytoma). The green ...
http://www.promega.com/cnotes/cn023/cn023.pdf...
|
Burger P[author] - PubMed Result
Antimalarial drug discovery: in silico structural biology and rational drug design. Infect Disord Drug Targets. 2009 Jun;9(3):304-18. Review. ...
http://www.ncbi.nlm.nih.gov/pubmed/?cmd=Search&term=Burger%2...
|
MEDLINE Abstracts: Farnesyl Transferase Inhibitors
Two drug families, the Benzodiazepine peptidomimetics and the CAAX ... Proliferation of Human Malignant Astrocytomas is Dependent on Ras Activation ...
The discovery that isoprenoid attachment is required for the aberrant ... All
material on this website is protected by copyright, Copyright © 1994-2009 by
Medscape. ...
http://www.medscape.com/viewarticle/433071...
|
New strategies to deliver anticancer drugs to brain tumors
Expert Opin Drug Deliv. Author manuscript; available in PMC 2009 October 1. ... Malignant astrocytomas constitute about 50% to 60% of primary brain tumors, ...
In the last decades, despite advances in anticancer drug discovery and ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752842/...
|
|
